Blog

 | by
Kaitlyn Vitez
Director, Make Higher Education Affordable Campaign

Big news (and savings) for students.

 | by
Matt Casale
Director, Environment Campaigns

Here's a guest post from our friend Meryl Compton at Frontier Group. Meryl writes about the challenges of deciding whether or not to ditch a car in a car-centric country.

 | by
Elizabeth Ridlington
Associate Director & Senior Policy Analyst, Frontier Group

Here are two things you probably don’t know about colonoscopies. First, they’re one of the most commonly performed screening exams. Millions of us get colonoscopies each year, but we don’t like to talk about it. Second, you probably don’t know how much a colonoscopy costs, even if you are a patient who has scheduled an exam. That’s because colonoscopies are like most health care services: patients don’t know the cost in advance of receiving care.

Landmark consumer legislation has had a monumental effect on protecting kids’ health.

 | by
Ed Mierzwinski
Senior Director, Federal Consumer Program

We've joined leading consumer, civil rights, labor and older American organizations in a comment letter urging the Securities and Exchange Commission (SEC) to strengthen its proposed "Regulation Best Interest" intended to ensure that all broker-dealers and other individuals and firms offering investment advice act do so in a fiduciary capacity, or in the best interest of their investor-clients. (Right now, it doesn't).

 | by
Mike Litt
Director, Campaign to Defend the Consumer Bureau

Today, we're releasing our revamped Identity Theft and Online Privacy resources.

 | by
Ed Mierzwinski
Senior Director, Federal Consumer Program

We joined leading consumer organizations to criticize the national bank regulator OCC's new proposal to charter non-bank fintech companies. We called it both illegal and a gateway for online predatory lenders to enter states where high-cost payday lending is banned. Leading state bank regulatory officials also opposed the OCC move, which is also one of the recommendations in a controversial Treasury Department report released the same day.

 | by
Ed Mierzwinski
Senior Director, Federal Consumer Program

In response to a Request for Information from the Department of Health and Human Services (HHS) to comment on its "Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs", we joined Consumers Union and other leading groups in a comment letter. In particular, we detail ways to rein in abusive and anti-competitive practices of both Pharmacy Benefit Managers (PBMs) and Big Pharma's brand name drug companies that force American consumers to pay too much for health care. Our comments support many of the proposals from Secretary Azar and HHS.

A recent article in the LA Times revealed that a new study found that the toxic compound triclosan, which is commonly found in toothpaste as well as other consumer products such as cosmetics, children’s toys, and yoga mats, “could cause adverse effects on colonic inflammation and colon cancer.”

 | by
Ed Mierzwinski
Senior Director, Federal Consumer Program

Monday, June 4, at midnight (ET) marks the deadline for filing public comments on the Consumer Financial Protection Bureau’s latest inward-facing Request For Information (RFI); this one is on the future of the public Consumer Complaint Database, which has been disparaged for years by various bank industry actors and their coin-operated think tanks but most recently by the CFPB’s acting director, Mick Mulvaney. Here's why we are fighting to keep the database public.